The incoming administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.
The incoming administration should work towards encouraging state health departments to develop clear and well-communicated data storage standards for newborn screening samples.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
NIST’s guidance on “Managing Misuse Risk for Dual-Use Foundation Models” represents a significant step forward in establishing robust practices for mitigating catastrophic risks associated with advanced AI systems.
What steps should the U.S. take to address China’s growing global share of legacy chip manufacturing?
As artificial intelligence evolves, so does the urgency for legislation to manage both the risks and opportunities associated with it.
Science holds the greatest benefit for society when its process is open, its methods are transparent, and its outputs are accessible. To achieve and sustain a scientific enterprise that is truly open, we need your help.
We’re looking for your big ideas to take U.S. global development practices to the next level – and to use innovation to improve lives around the world.
We engage with the public, academia, and the private sector to foster a broader understanding of AI and emerging technology policy issues.
We’re scoping ambitious ideas to help ARPA-I begin executing projects that improve transportation across the country.
The U.S. bioeconomy is growing rapidly, innovation is needed to sustain and maintain this growth. Shaping policy to consider workforce development, advanced agriculture, bioindustrial and biotech sectors will be imperative to keep the needle moving forward.
We aim to catalyze a more nimble science funding ecosystem, capable of keeping up with and facilitating new innovations to improve the lives of people around the world.
